Gary S. Sachs, MD
Associate Professor of Psychiatry, Harvard Medical School
Director, Bipolar Clinic and Research Program, Massachusetts General Hospital, Boston, Massachusetts
Dr. Sachs has disclosed that he is the recipient of research grants from Abbott, GlaxoSmithKline, Janssen, Repligen, Pfizer, and Wyeth; is a consultant for Abbott, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Eli Lilly, Janssen, JDS, Memory, Repligen, Pfizer, Solvay, and Wyeth; and is a member of the speakers bureaus of Abbott, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, and Eli Lilly. The editors of The Carlat Psychiatry Report have reviewed the content of Dr. Goddard’s interview and have resolved any financial conflicts of interest regarding this educational activity. The author has disclosed that inositol has not been approved by the U.S. Food and Drug Administration for use in the treatment of bipolar disorder.
Dr. Sachs, as the principal investigator of the STEP-BD study, can you walk us through how the study was hatched?
While it’s certainly interesting to theorize about neurotransmitters and antidepressants, the recent STAR*D findings bring up a difficult topic: Does mechanism matter?
Dopamine is the new serotonin: everyone is talking about it. Depending on what authority you read, dopamine is central to schizophrenia, ADHD, depression, sexuality, and cognition.
Anticholinergic-speak is endemic in psychiatry. Since it’s unlikely to go away, we invite you to buff up your knowledge of acetylcholine (ACh) and to review the many ways in which it makes an appearance in clinical practice.
Samuel H. Barondes, MD
Jeanne and Sanford Robertson Professor of Psychiatry
Director of the Center for Neurobiology and Psychiatry
University of California, San Francisco School of Medicine
Author, Molecules and Mental Illness, Mood Genes, and Better Than Prozac
Dr. Barondes has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.
Dr. Barondes, you were a researcher at the NIH during the period when the earliest research on neurotransmitters and antidepressants was conducted. What happened while you were there?
Julius Axelrod, who won the Nobel Prize for his work in neuroscience, spent much of his career as a lab tech. Born in 1912 on the Lower East Side of Manhattan, he got most of his education at the tuition-free City College of New York, which he described as a “proletarian Harvard.”